A prognostic index for locoregional recurrence after neoadjuvant chemotherapy.
CONCLUSIONS: Patients with a score of 0, which made up to 19% of the study population, had very low risk of LRR. The score enabled the identification of a small group (7%) of patients with very high risk of LRR, and who may benefit from alternative treatment.
PMID: 27433280 [PubMed]
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
More News: Breast Cancer | Breast Carcinoma | Breast Conservation Surgery | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | Databases & Libraries | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | HER2 | Herceptin | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Statistics | Study